362 related articles for article (PubMed ID: 18585966)
1. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years.
Friedman S; Rubin PH; Bodian C; Harpaz N; Present DH
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):993-8; quiz 953-4. PubMed ID: 18585966
[TBL] [Abstract][Full Text] [Related]
2. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic problems and advances in inflammatory bowel disease.
Odze R
Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
[TBL] [Abstract][Full Text] [Related]
5. Screening and surveillance colonoscopy in chronic Crohn's colitis.
Friedman S; Rubin PH; Bodian C; Goldstein E; Harpaz N; Present DH
Gastroenterology; 2001 Mar; 120(4):820-6. PubMed ID: 11231935
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
[TBL] [Abstract][Full Text] [Related]
7. Screening and surveillance of ulcerative colitis.
Axon AT
Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):129-45. PubMed ID: 8995118
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening and surveillance in Crohn's colitis.
Basseri RJ; Basseri B; Vassilaki ME; Melmed GY; Ippoliti A; Vasiliauskas EA; Fleshner PR; Lechago J; Hu B; Berel D; Targan SR; Papadakis KA
J Crohns Colitis; 2012 Sep; 6(8):824-9. PubMed ID: 22398087
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.
Thomas T; Abrams KA; Robinson RJ; Mayberry JF
Aliment Pharmacol Ther; 2007 Mar; 25(6):657-68. PubMed ID: 17311598
[TBL] [Abstract][Full Text] [Related]
10. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.
Marion JF; Waye JD; Present DH; Israel Y; Bodian C; Harpaz N; Chapman M; Itzkowitz S; Steinlauf AF; Abreu MT; Ullman TA; Aisenberg J; Mayer L;
Am J Gastroenterol; 2008 Sep; 103(9):2342-9. PubMed ID: 18844620
[TBL] [Abstract][Full Text] [Related]
11. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidy.
Sjöqvist U; Befrits R; Söderlund S; Ost A; Karlén P; Tribukait B; Rubio C; Rutgeerts P; Geboes K; Löfberg R
Anticancer Res; 2005; 25(6C):4393-7. PubMed ID: 16334114
[TBL] [Abstract][Full Text] [Related]
13. The fate of low grade dysplasia in ulcerative colitis.
Ullman TA; Loftus EV; Kakar S; Burgart LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 2002 Apr; 97(4):922-7. PubMed ID: 12008669
[TBL] [Abstract][Full Text] [Related]
14. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
15. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
16. Incident rates of colonic neoplasia in older patients: when should we stop screening?
Harewood GC; Lawlor GO; Larson MV
J Gastroenterol Hepatol; 2006 Jun; 21(6):1021-5. PubMed ID: 16724989
[TBL] [Abstract][Full Text] [Related]
17. Dysplasia associated with Crohn's colitis: segmental colectomy or more extended resection?
Kiran RP; Nisar PJ; Goldblum JR; Fazio VW; Remzi FH; Shen B; Lavery IC
Ann Surg; 2012 Aug; 256(2):221-6. PubMed ID: 22791098
[TBL] [Abstract][Full Text] [Related]
18. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
19. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
20. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
